Closed
SectorHealthcare
10.65 -1.02
24h
Min
10.6
Max
10.86
Income | 212M 25M |
---|---|
Sales | 4.5M 9M |
EPS | -0.199 |
Profit margin | 280.018 |
Employees | 908 |
EBITDA | -52M -274M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +63.79% upside |
Market Cap | 7.8B |
---|---|
Previous open | 11.67 |
Previous close | 10.65 |
By Acuity
50%
50%
187 / 382 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 18 USD 63.79%
High 18 USD
Low 18 USD
Based on 5 Wall Street analysts offering 12 month price targets forRoivant Sciences Ltd - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$